Jun 23, 2024, 19:16
Joshua Richter: Amazing Paper on Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma
Joshua Richter, Associate Professor of Medicine, Hematology, and Medical Oncology at The Tisch Cancer Institute, shared on X/Twitter:
“Honored to by co-lead author with Naresh Bumma on this amazing paper: Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma | Journal of Clinical Oncology.”
Visit the article site.
Source: Joshua Richter/X
Anasuya Hazra
Anita Boyapati
Attaya Suvannasankha
cancer
Chang-Ki Min
Dhruti Chokshi
George D. Yancopoulos
Glenn S. Kroog
Hans C. Lee
Hematology
Ja Min Byun
James E. Hoffman
Jeffrey A. Zonder
Jing Christine Ye
Joaquín Martínez-Lopez
Joseph J. Maly
Joshua Richter
Journal of Clinical Oncology
Ka Lung Wu
Kaniel Cassady
Karen Rodriguez Lorenc
L. Andres Sirulnik
Linvoseltamab
Madhav V. Dhodapkar
Mansi R. Shah
Marie-Christiane Vekemans
Markus Munder
Matthew J. Pianko
Michelle DeVeaux
Naresh Bumma
OncoDaily
Oncology
Rachid Baz
Rebecca Silbermann
relapsed/refractory multiple myeloma
Sundar Jagannath
Suzanne Lentzsch
Swathi Namburi
Yariv Houvras
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 08:59
Nov 13, 2024, 08:39